Gemfibrozil in the treatment of dyslipidaemia. A 5-year follow-up study.
Manninen V, Mälkönen M, Eisalo A, +3 more·Acta medica Scandinavica. Supplementum
Abstract not available
Searching PubMed for “Clinical Trial” and checking full-text availability…
for “Clinical Trial” · Showing 8,521–8,540 · 2305 ms
Manninen V, Mälkönen M, Eisalo A, +3 more·Acta medica Scandinavica. Supplementum
Abstract not available
Giorgi-Conciato M, Daniotti S, Ferrari P A, +4 more·Scandinavian journal of gastroenterology. Supplement
Abstract not available
Stephen K W, Boyle I T, Campbell D, +4 more·British dental journal
Abstract not available
Reid W H, Ahmed I, Levie C A·American journal of psychotherapy
A single-blind, rater-blind, modified crossover design was used to evaluate a simple, practical method of clinical treatment of sleepwalking. Subjects who had severe somnambulism, but were otherwise free of psychiatric illness, responded well to six brief sessions of specialized hypnotherapy. Follow-up at one year has…
Bunch T W·Arthritis and rheumatism
Two groups of patients with polymyositis have been followed for approximately 3 years. One group was treated with prednisone alone and the other with prednisone plus azathioprine. Although the polymyositis of both groups has improved, no statistically significant difference was noted at the end of 3 months, as previous…
Gitlin M J, Gerner R H, Rosenblatt M·Psychopharmacology
Naltrexone, a long acting opiate antagonist, and placebo were administered to eight schizophrenics in doses of 200 mg per day for 1 week in a double-blind, crossover design. No improvement was noted, and no side effects resembling the opiate withdrawal syndrome with naltrexone were found. Naltrexone does not appear to…
Brockmann P, Hennies W·Die Medizinische Welt
Abstract not available
Coster D J, Wilhelmus K R, Michaud R, +1 more·The British journal of ophthalmology
Sixty patients were treated with either acyclovir 2% ointment or idoxuridine 1% ointment 5 times a day in a stratified randomised double-blind clinical trial. The 2 antiviral agents were equally effective.
Pathy M S, Reynolds A J·Postgraduate medical journal
Six of 14 patients receiving a sustained release papaverine preparation developed abnormal liver function tests. One patient had jaundice and another abnormal liver histology on a biopsy specimen. This is only the third report of impaired liver function following the administration of papaverine--a drug which has been…
Smyth G D, Singh R, Hassard T H·Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
To discover whether removal of the canal wall would reduce the incidence of postoperative cholesteatoma in tympanoplasty, the findings in staged, intact canal wall tympanoplasties were compared with those in staged, modified radical mastoidectomies with cavity obliteration and tympanoplasty. In all, cholesteatoma was c…
Scott G M, Reed S, Cartwright T, +1 more·Archives of virology
Volunteers were treated with fibroblast interferon or placebo nose drops for four days. On the second day, they received a challenge with rhinovirus type 4. There was no difference in the clinical symptoms or viral shedding between the two groups. The possible reasons for this result are discussed.
Mulvihill-Wilson J, Graham R M, Pettinger W A, +4 more·Cardiology
Abstract not available
Taylor M C, Bates C P·British journal of urology
Forty patients with the unstable bladder syndrome have been treated in a double-blind crossover trial of baclofen 5 mg qds versus placebo. Baclofen significantly improved diurnal and nocturnal frequency of micturition and the severity of incontinence. Considerable improvement was also obtained with placebo.
Jeffcoate W J, Herbert M, Cullen M H, +2 more·Lancet (London, England)
In a double-blind, cross-over study of twenty male volunteers intravenous injection of 0.4 mg naloxone prevented the impairment of psychomotor performance induced by low levels of blood alcohol. The possibility that alcohol produces intoxication by stimulating the release of endogenous opioid peptides should be investi…
Traissac L, Roche J C·Revue de laryngologie - otologie - rhinologie
Abstract not available
Gonvers J J, Birchler R, Hofstetter J R, +3 more·Schweizerische medizinische Wochenschrift
55 patients with endoscopically confirmed duodenal ulcers received either cimetidine (26 patients) or placebo (29 patients) in a double-blind trial. At four weeks, 85% of the patients treated with cimetidine and 62% of those receiving placebo had endoscopically healed ulcers. This difference is not statistically signif…
Liern Caballero M, Alberola Carbonell C, Climent Pérez J L, +1 more·Rhinology
A controlled trial comparing sodium cromoglycate 2% nasal solution against placebo has demonstrated that in patients with severe perennial rhinitis sodium cromoglycate is clinically effective and also that gross histological changes in the nasal mucosa are reversed following treatment for eight weeks with this therapy.
Falliers C J·Chest
Abstract not available
Tamminga C A, Schaffer M H, Smith R C, +1 more·Science (New York, N.Y.)
Eighteen chronic schizophrenic patients received subcutaneous doses of apomorphine, a dopamine receptor agonist, and of placebo in separate trials. A significant improvement in psychotic symptoms occurred after apomorphine compared to placebo. The results are interpreted as a consequence of presynaptic dopamine recepto…
Wilson A, Davidson W J, Blanchard R, +1 more·Journal of studies on alcohol
Ten alcoholics implanted with disulfiram had longer periods of abstinence after treatment than did 10 alcoholics implanted with placebo; 7 of the disulfiram-implanted patients experienced a disulfiram-ethanol reaction in uncontrolled drinking situations, while none of the placebo-implanted patients did.